靶向纳米载体募集肺血管内白细胞将药物递送至损伤的大脑。

Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain.

机构信息

Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, United States.

出版信息

ACS Nano. 2023 Jul 25;17(14):13121-13136. doi: 10.1021/acsnano.2c08275. Epub 2023 Jul 11.

Abstract

-loaded white blood cells (WBC) can transfer cargo to pathological foci in the central nervous system (CNS). Here we tested affinity ligand driven loading of WBC in order to bypass the need for WBC manipulation. We used a mouse model of acute brain inflammation caused by local injection of tumor necrosis factor alpha (TNF-α). We intravenously injected nanoparticles targeted to intercellular adhesion molecule 1 (anti-ICAM/NP). We found that (A) at 2 h, >20% of anti-ICAM/NP were localized to the lungs; (B) of the anti-ICAM/NP in the lungs >90% were associated with leukocytes; (C) at 6 and 22 h, anti-ICAM/NP pulmonary uptake decreased; (D) anti-ICAM/NP uptake in brain increased up to 5-fold in this time interval, concomitantly with migration of WBCs into the injured brain. Intravital microscopy confirmed transport of anti-ICAM/NP beyond the blood-brain barrier and flow cytometry demonstrated complete association of NP with WBC in the brain (98%). Dexamethasone-loaded anti-ICAM/liposomes abrogated brain edema in this model and promoted anti-inflammatory M2 polarization of macrophages in the brain. targeted loading of WBC in the intravascular pool may provide advantages of coopting WBC predisposed to natural rapid mobilization from the lungs to the brain, connected directly via conduit vessels.

摘要

-负载白细胞 (WBC) 可以将货物转移到中枢神经系统 (CNS) 的病变部位。在这里,我们测试了亲和配体驱动的 WBC 加载,以绕过对 WBC 操作的需求。我们使用了由肿瘤坏死因子 alpha (TNF-α) 局部注射引起的急性脑炎症的小鼠模型。我们静脉注射了针对细胞间黏附分子 1 (anti-ICAM/NP) 的纳米颗粒。我们发现:(A) 在 2 小时时,超过 20%的 anti-ICAM/NP 定位于肺部;(B) 肺中的 anti-ICAM/NP 中超过 90%与白细胞相关;(C) 在 6 和 22 小时时,anti-ICAM/NP 的肺摄取减少;(D) 在这段时间内,anti-ICAM/NP 在大脑中的摄取增加了 5 倍,同时白细胞也迁移到受伤的大脑中。活体显微镜证实了 anti-ICAM/NP 超越血脑屏障的转运,流式细胞术证明了 NP 在大脑中与 WBC 的完全结合 (98%)。地塞米松负载的 anti-ICAM/脂质体在该模型中减轻了脑水肿,并促进了大脑中巨噬细胞的抗炎 M2 极化。在血管内池中的 WBC 靶向加载可能具有优势,可以利用已经倾向于通过导管血管从肺部快速迁移到大脑的白细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e86/10373654/6aea8594ea0a/nn2c08275_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索